ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 61 filers reported holding ESSA PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,387,000 | -71.3% | 1,311,294 | -50.3% | 0.06% | -74.4% |
| Q2 2022 | $8,307,000 | -49.0% | 2,637,192 | 0.0% | 0.22% | -36.2% |
| Q1 2022 | $16,298,000 | -56.5% | 2,637,192 | 0.0% | 0.34% | -38.4% |
| Q4 2021 | $37,448,000 | +77.5% | 2,637,192 | 0.0% | 0.55% | +72.0% |
| Q3 2021 | $21,098,000 | -75.8% | 2,637,192 | -13.6% | 0.32% | -75.9% |
| Q2 2021 | $87,250,000 | +958.7% | 3,053,919 | +976.5% | 1.32% | +920.9% |
| Q1 2021 | $8,241,000 | – | 283,692 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,145,117 | $12,310,997 | 1.28% |
| BVF INC/IL | 8,748,629 | $25,983,428 | 0.95% |
| Ally Bridge Group (NY) LLC | 236,583 | $702,652 | 0.92% |
| PFM Health Sciences, LP | 4,161,461 | $12,359,539 | 0.55% |
| Bellevue Group AG | 7,898,583 | $23,458,792 | 0.34% |
| Rhenman & Partners Asset Management AB | 356,500 | $1,051,675 | 0.12% |
| Orbimed Advisors | 1,198,337 | $3,559,061 | 0.07% |
| Privium Fund Management (UK) Ltd | 20,032 | $61,498 | 0.05% |
| Rock Springs Capital Management LP | 524,944 | $1,559,084 | 0.04% |
| Hunting Hill Global Capital, LLC | 10,000 | $29,700 | 0.02% |